Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19

Chloroquine (CQ) and its derivative, hydroxychloroquine (HCQ), have attracted wide attention for treating coronavirus disease 2019 (COVID-19). However, conflicting outcomes have been found in COVID-19 clinical trials after treatment with CQ or HCQ. To date, it remains uncertain whether CQ and HCQ ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Tzu-Chuan, Wang, Yung-Hsuan, Chen, Yi-Ling, Tsai, Wan-Chi, Lee, Che-Hsin, Chuang, Kuo-Pin, Chen, Yi-Ming Arthur, Yuan, Cheng-Hui, Ho, Sheng-Yow, Yang, Ming-Hui, Tyan, Yu-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922580/
https://www.ncbi.nlm.nih.gov/pubmed/33671315
http://dx.doi.org/10.3390/pathogens10020217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922580/
https://www.ncbi.nlm.nih.gov/pubmed/33671315
http://dx.doi.org/10.3390/pathogens10020217

Ejemplares similares